about
Utilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisOxidative Stress and Liver Cancer: Etiology and Therapeutic TargetsKey role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinomaViruses and human cancers: a long road of discovery of molecular paradigms.Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Clinical implications of hepatitis B virus mutations: recent advances.Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.Establishment of animal models with orthotopic hepatocellular carcinoma.Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinomaSomatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinomaHepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathwayDownregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular CarcinomaStabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation.Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation.The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillanceRemoval of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?HBxAg suppresses apoptosis of human placental trophoblastic cell lines via activation of the PI3K/Akt pathway.The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cellsHTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis.Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.Pre- and post-operative HBsAg levels may predict recurrence and survival after curative resection in patients with HBV-associated hepatocellular carcinoma.Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.Follicular helper T cell exhaustion induced by PD-L1 expression in hepatocellular carcinoma results in impaired cytokine expression and B cell help, and is associated with advanced tumor stages.The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state.HBx induces the proliferation of hepatocellular carcinoma cells via AP1 over-expressed as a result of ER stress.Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.
P2860
Q26748807-ED854454-18B3-4C9E-AFE0-46F80E2A71F1Q26751392-8F281AC2-B2D2-476B-8481-3ABF71839F8CQ26823512-198426AF-52E7-4D65-A3DB-A0591B90C879Q28071678-53EFADC2-259F-40C4-94D3-06F2361E58FAQ28084458-78C14DC4-52D8-4E9C-AD74-B7490E062DB8Q30384388-DD7E4608-8653-492F-B6AA-29CBE162F1D1Q31114379-C5310BEB-4EB1-4E40-B314-499A6EE4D8A9Q33801311-A095F2FA-FE42-4756-BB4C-008C9A59353EQ34067936-57639E35-A1C8-4A26-9574-0BC6D7943FE9Q34090895-83ADE727-3CCE-4457-9560-DB33FCB9243BQ34427154-D7EC367D-32D4-44EA-A91F-880C3A8915C8Q35029955-009431E5-EC7B-43CA-83CD-1A05FD2B4E1AQ35636725-19E888EE-129A-4FE1-A0BE-CB7D9D0F199FQ35742116-7DED528D-BC06-4AC3-A16C-CB301E2D34D1Q35781420-78E847E7-E1E3-4AEC-82EC-7127BB2AB232Q35826547-BD8B3BD4-D398-4520-B766-6693058B8BF4Q35978719-860CE904-E6BB-48F8-8C22-BB086E062D32Q36005233-76589AA2-9478-4471-A5E3-635AE1E8BB58Q36129012-ADD597DE-1D23-4981-9AE9-0F64AB2A6EF2Q36619079-96C82F31-038E-46A8-9AA2-5E0304D36251Q37257069-0A11AE41-E02D-4A26-B386-5DAB52F30B41Q37525796-C98B1F69-D5F8-4EB4-99D4-622EE205E625Q37530615-86BE27B3-3A73-4E5A-9AF7-5FB07F19717CQ37605874-42902685-C0A3-44D3-A4E5-E6213332D0DCQ37636590-CAF2BE11-A734-4F60-9238-E5CD5ACA3ADDQ37714431-9769B0ED-9BD5-483A-8DFE-E147CE775E0DQ38466831-709E7655-DBC8-4A90-93D9-D3FDC4B4903BQ38782761-52ACDBE1-2AE4-416D-94DF-B0461AFFAE0EQ38818824-63810198-8FFF-419C-8300-28B20ECF325AQ39614932-ED289A7D-3EFF-4D4F-B7F4-397179725264Q40056788-26F99887-199E-45E7-8589-141A65C2E18DQ40068189-B9349A63-2F73-462E-98CA-1887FB242032Q40128942-57F72936-7ECA-42E6-BDBF-4FDC20016CAAQ40154210-BF9A8ED6-BDC6-4141-A7DD-C6C136D4829DQ40484496-B108B8E9-3419-4C1F-A453-18B35865183FQ40503744-26D512D9-EB4A-4C6D-8C2A-A851B59F9917Q40628628-016FA95B-FF5D-4DFF-949E-2D62825AC2F6Q40676461-84DCB08B-598B-4103-9F69-8BAA0BF2CE82Q41646513-EE4BC588-76D1-400C-9AF4-74B7472542DAQ41926688-12379FDF-2222-4CD5-894E-01711E020DE8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatitis B virus-induced hepatocellular carcinoma.
@en
type
label
Hepatitis B virus-induced hepatocellular carcinoma.
@en
prefLabel
Hepatitis B virus-induced hepatocellular carcinoma.
@en
P2093
P1433
P1476
Hepatitis B virus-induced hepatocellular carcinoma.
@en
P2093
Liang Qiao
Wence Zhou
Yuming Wang
P304
P356
10.1016/J.CANLET.2013.08.035
P407
P577
2013-08-25T00:00:00Z